CHICAGO -- U.S. employers, struggling to tame double-digit health inflation, are putting the squeeze on AstraZeneca's ulcer drug Nexium, a product the Anglo-Swedish drug maker sorely needs to boost ...
Pharmaceutical company AstraZeneca said Tuesday it will pay $425 million to settle lawsuits from people who experienced kidney damage from the company’s heartburn medications Nexium and Prilosec. File ...
(RTTNews) - British drug major AstraZeneca Plc (AZN.L, AZN) announced Tuesday that it has entered into settlement agreements in the product liability litigations related to Nexium and Prilosec. The ...
correctionA May 8 article misstated the amount of money spent in 2004 advertising the heartburn medication Nexium. The correct figure is $200 million, not $2.2 million. (Published 5/19/2005) Beginning ...
Are you a print subscriber? Activate your account. By Parker Herren - 10 min 20 sec ago By Bradley Johnson - 29 min 35 sec ago By Tim Nudd - 1 hour 52 min ago By Jon Springer - 4 hours 22 min ago By E ...
Oct 3 (Reuters) - British drugmaker AstraZeneca AZN.L on Tuesday said it will pay $425 million to settle product liability litigations against prescription-only acid-reflux medicine Nexium and ...
This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. The Food and Drug Administration warned today that patients taking the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results